Pupa, S.M.; Ligorio, F.; Cancila, V.; Franceschini, A.; Tripodo, C.; Vernieri, C.; Castagnoli, L.
HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness. Cancers 2021, 13, 4778.
https://doi.org/10.3390/cancers13194778
AMA Style
Pupa SM, Ligorio F, Cancila V, Franceschini A, Tripodo C, Vernieri C, Castagnoli L.
HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness. Cancers. 2021; 13(19):4778.
https://doi.org/10.3390/cancers13194778
Chicago/Turabian Style
Pupa, Serenella M., Francesca Ligorio, Valeria Cancila, Alma Franceschini, Claudio Tripodo, Claudio Vernieri, and Lorenzo Castagnoli.
2021. "HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness" Cancers 13, no. 19: 4778.
https://doi.org/10.3390/cancers13194778
APA Style
Pupa, S. M., Ligorio, F., Cancila, V., Franceschini, A., Tripodo, C., Vernieri, C., & Castagnoli, L.
(2021). HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness. Cancers, 13(19), 4778.
https://doi.org/10.3390/cancers13194778
